# A First-In-Human Phase 1b Study of AmnioPul-02 in COVID-19 / Other LRTI

> **NCT05348772** · PHASE1 · COMPLETED · sponsor: **Amniotics AB** · enrollment: 6 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** AmnioPul-02

## Key facts

- **NCT ID:** NCT05348772
- **Lead sponsor:** Amniotics AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-10
- **Primary completion:** 2023-02-09
- **Final completion:** 2023-02-09
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2023-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05348772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05348772, "A First-In-Human Phase 1b Study of AmnioPul-02 in COVID-19 / Other LRTI". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05348772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*